Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2019/esmo-2019-prostate-cancer/115353-esmo-2019-health-related-quality-of-life-in-a-randomized-phase-3-trial-of-enzalutamide-with-standard-first-line-therapy-for-mhspc-enzamet-an-anzup-led-international-co-operative-group-trial
If you do not want to visit that page, you can close this browser tab.
